- Prediction of survival of HPV16-negative, p16-negative oral cavity cancer patients using a 13-gene signature: A multicenter study using FFPE samples2020 | First Faculty of Medicine
- Distant metastases from lip and oral cavity cancer2001 | Publication without faculty affiliation
- Distans Metastases from Lip and oral Cavity Cancer, ORL2001 | First Faculty of Medicine
- Marginal versus Segmental Mandibulectomy in the Treatment of Oral Cavity Cancer: A Systematic Review and Meta-analysis2023 | First Faculty of Medicine
- The influence of smoking, age and stage at diagnosis on the survival after larynx, hypopharynx and oral cavity cancers in Europe: The ARCAGE study2018 | First Faculty of Medicine
- HPV and RAD51 as Prognostic Factors for Survival in Inoperable Oral and Oropharyngeal Cancer in Patients Unfit for Chemotherapy Treated with Hyperfractionated Radiotherapy2023 | Third Faculty of Medicine
- Life course social mobility and risk of upper aerodigestive tract cancer in men2010 | First Faculty of Medicine
- Novel Local Chimeric Flap Based on Tunnelized Facial Artery Myomucosal Island Flap and Submandibular Gland Flap for Reconstructions after Oral Squamous Cell Carcinoma Surgery2023 | Faculty of Medicine in Pilsen
- Determining priority risk groups for compensation of treatment breaks in radical radiotherapy in patients with locally advanced head and neck cancer2021 | First Faculty of Medicine, Central Library of Charles University
- Study of Metallothionein Role in Spinocellular Carcinoma Tissues of Head and Neck Tumours using Brdicka Reaction2012 | Faculty of Science, Second Faculty of Medicine
- Study of Metallothionein Role in Spinocellular Carcinoma Tissues of Head and Neck Tumours using Brdicka Reaction2012 | Second Faculty of Medicine
- Metallothionein Electrochemically Determined using Brdicka Reaction as a Promising Blood Marker of Head and Neck Malignant Tumours2012 | Faculty of Science, Second Faculty of Medicine
- Metallothionein Electrochemically Determined using Brdicka Reaction as a Promising Blood Marker of Head and Neck Malignant Tumours2012 | Second Faculty of Medicine